8-K ·Filed Jul 29, 2026

GEHC

GE HealthCare Technologies Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001932393-26-000047
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a purely administrative segment realignment filing. No trading action is warranted. Monitor the next quarterly report for any operational or financial impact from the new structure.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
GEHC ▲ +1.96% at T+20d
NEUTRAL call ✓ call won +1.96% · α vs SPY -3.06% · entry $71.90 → $73.31
Next anchor: T+60d in 20d
Latest observation: T+44 +4.47% FF3 residual α
Entry anchored
Jul 28, 03:59 PM ET
via exchange tick
T+1d
-2.73%
call -2.73% · α -4.40%
$69.94
settled 2mo ago
T+5d
-2.31%
call -2.31% · α -7.84%
$70.24
settled 8w ago
T+20d
+1.96%
call +1.96% · α -3.06%
$73.31
settled 5w ago
T+60d
—
call — · α —
—
in 20d

Price Chart

Loading chart...

Executive Summary

GE HealthCare filed an 8-K to disclose a change in its reportable segment structure, combining Imaging and Advanced Visualization Solutions into a new Advanced Imaging Solutions (AIS) segment. The filing includes recast unaudited historical financials for comparability but does not report any new financial results or guidance for the current period. This is a routine organizational realignment with no immediate financial impact.

Key Facts

  • GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new segment, Advanced Imaging Solutions (AIS), in Q2 2026.
  • The company now operates three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).
  • Recast unaudited historical financials were provided for Q1 2026, FY2025, FY2024, and quarterly periods within those years.
  • Total revenues for Q1 2026 were $5,131 million, compared to $4,777 million in Q1 2025.
  • Organic revenue growth for total company was 2.9% in Q1 2026.
  • Segment EBIT for AIS was $479 million, PDx $197 million, and PCS $10 million in Q1 2026.
  • The filing does not contain any new earnings results, guidance updates, or material financial events.

Financial Impact

No new financial impact; recast data is for comparability only.

segment revenuesegment EBIT

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Analyst Consensus
68% bullish (28 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001932393-26-000047
Document: gehc-20260729.htm0001932393-26-000047
Document: 0001932393-26-000047-index-headers.html0001932393-26-000047
Document: 0001932393-26-000047-index.html0001932393-26-000047
Document: 0001932393-26-000047.txt0001932393-26-000047
7 reports for GEHC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GEHC — sortable, filterable
TypeNow
Jul 29, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$71.90 $73.31▲ +1.96%▼ −3.06%$64.17 (−10.75%)
May 13, 2026
20w ago
Insider Cluster
NEUTRAL ★ 2/10
$64.26 $61.59▼ −4.16%▼ −4.90%$64.17 (−0.14%)
May 11, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$62.29 $63.76▲ +2.36%▲ +4.09%$64.17 (+3.02%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 4/10
$60.84 $62.86▲ +3.32%▼ −1.65%$64.17 (+5.47%)
Apr 30, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$60.84 $62.86▲ +3.32%▼ −1.65%$64.17 (+5.47%)
Apr 29, 2026
22w ago
8-K
BEARISH ★ 7/10
$59.49 $63.88▼ −7.39%▼ −1.93%$64.17 (−7.88%)
Mar 19, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$70.35 $74.66▲ +6.13%▼ −1.49%$64.17 (−8.78%)
Showing 7 of 7

US Market Status

Market Open — Closes in 6h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access